No Data
No Data
Express News | BridgeBio Pharma Inc : Leerink Partners Raises Target Price to $53 From $50
BridgeBio Pharma Q1 Loss Widens, Revenue Drops
Earnings Call Summary | BridgeBio Pharma(BBIO.US) Q1 2025 Earnings Conference
TD Cowen Maintains BridgeBio Pharma(BBIO.US) With Buy Rating
BridgeBio Pharma | 10-Q: Quarterly report
BridgeBio Pharma Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results.